Shree Pacetronix Limited has confirmed that there were no deviations or variations in the utilization of funds raised through a preferential issue. This statement pertains to the quarter and half-year ended September 30, 2026. The company’s Audit Committee reviewed and the Board of Directors recorded this confirmation, assuring stakeholders about the proper deployment of capital.
Confirmation of Fund Utilization
Shree Pacetronix Limited has issued a formal statement regarding the utilization of funds raised via a preferential issue. The company confirmed that there have been no deviations or variations in how these funds were used during the quarter and the half-year period that concluded on September 30, 2026.
This confirmation is in line with the requirements of Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The statement also references SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185, dated December 31, 2024, and the SEBI Master Circular dated January 30, 2026.
Audit Committee and Board Review
The company further stated that the utilization of these funds was thoroughly reviewed by its Audit Committee. Subsequently, the Board of Directors has taken this statement on record. This process ensures transparency and adherence to regulatory guidelines concerning the deployment of capital raised from preferential issues.
Details of Fund Raising
The preferential issue involved the allotment of equity shares and warrants. Specifically, on November 14, 2025, 75,150 equity shares were allotted, raising Rs. 60,87,150. On the same date, 75,150 Series A warrants and 1,50,300 Series B warrants were also issued, with an upfront receipt of Rs. 15,21,787.5 (25% of total consideration). Later, on March 20, 2026, 75,150 Series A warrants were converted into equity shares upon receipt of the balance consideration of Rs. 45,65,362.50. The Series B warrants remained outstanding.
The total amount raised was Rs. 243.48 Lakhs (approximately ₹2.43 Crores), with Rs. 152.18 Lakhs (approximately ₹1.52 Crores) received at the time of allotment. The funds were allocated for both capital expenditure and general corporate purposes, with a significant portion of 99.11 Lakhs directed towards capital expenditure for manufacturing facilities, and 0.74 Lakhs for general corporate purposes.
Source: BSE
